Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of a predictor of one-year mortality in older patients with cancer by geriatric and oncologic parameters.
Giannotti C, Zoppoli G, Ferrando L, Murialdo R, Caffa I, Laudisio A, Scabini S, Romairone E, Fregatti P, Friedman D, Odetti P, Nencioni A, Ballestrero A, Monacelli F. Giannotti C, et al. Among authors: murialdo r. J Geriatr Oncol. 2020 May;11(4):610-616. doi: 10.1016/j.jgo.2019.10.018. Epub 2019 Nov 6. J Geriatr Oncol. 2020. PMID: 31706829
Bi-weekly docetaxel and gemcitabine regimen in her-2-negative and anthracycline-pretreated metastatic breast cancer patients: a multicenter phase II trial.
Murialdo R, Bertolotti F, Pastorino G, Mencoboni M, Bergaglio M, Folco U, Cinzia N, Vaira F, Simoni C, Canobbio L, Parodi M, Brema F, Ballestrero A. Murialdo R, et al. Cancer Chemother Pharmacol. 2011 Oct;68(4):1009-16. doi: 10.1007/s00280-011-1570-7. Epub 2011 Feb 16. Cancer Chemother Pharmacol. 2011. PMID: 21327683 Clinical Trial.
Her2 assessment using quantitative reverse transcriptase polymerase chain reaction reliably identifies Her2 overexpression without amplification in breast cancer cases.
Zoppoli G, Garuti A, Cirmena G, di Cantogno LV, Botta C, Gallo M, Ferraioli D, Carminati E, Baccini P, Curto M, Fregatti P, Isnaldi E, Lia M, Murialdo R, Friedman D, Sapino A, Ballestrero A. Zoppoli G, et al. Among authors: murialdo r. J Transl Med. 2017 May 1;15(1):91. doi: 10.1186/s12967-017-1195-7. J Transl Med. 2017. PMID: 28460632 Free PMC article.
Clinico-pathological associations and concomitant mutations of the RAS/RAF pathway in metastatic colorectal cancer.
Isnaldi E, Garuti A, Cirmena G, Scabini S, Rimini E, Ferrando L, Lia M, Murialdo R, Tixi L, Carminati E, Panaro A, Gallo M, Grillo F, Mastracci L, Repetto L, Fiocca R, Romairone E, Zoppoli G, Ballestrero A. Isnaldi E, et al. Among authors: murialdo r. J Transl Med. 2019 Apr 29;17(1):137. doi: 10.1186/s12967-019-1879-2. J Transl Med. 2019. PMID: 31036005 Free PMC article.
Development of a long non-coding RNA signature for prediction of response to neoadjuvant chemoradiotherapy in locally advanced rectal adenocarcinoma.
Ferrando L, Cirmena G, Garuti A, Scabini S, Grillo F, Mastracci L, Isnaldi E, Marrone C, Gonella R, Murialdo R, Fiocca R, Romairone E, Ballestrero A, Zoppoli G. Ferrando L, et al. Among authors: murialdo r. PLoS One. 2020 Feb 5;15(2):e0226595. doi: 10.1371/journal.pone.0226595. eCollection 2020. PLoS One. 2020. PMID: 32023246 Free PMC article.
Safety and Feasibility of Fasting-Mimicking Diet and Effects on Nutritional Status and Circulating Metabolic and Inflammatory Factors in Cancer Patients Undergoing Active Treatment.
Valdemarin F, Caffa I, Persia A, Cremonini AL, Ferrando L, Tagliafico L, Tagliafico A, Guijarro A, Carbone F, Ministrini S, Bertolotto M, Becherini P, Bonfiglio T, Giannotti C, Khalifa A, Ghanem M, Cea M, Sucameli M, Murialdo R, Barbero V, Gradaschi R, Bruzzone F, Borgarelli C, Lambertini M, Vernieri C, Zoppoli G, Longo VD, Montecucco F, Sukkar SG, Nencioni A. Valdemarin F, et al. Among authors: murialdo r. Cancers (Basel). 2021 Aug 9;13(16):4013. doi: 10.3390/cancers13164013. Cancers (Basel). 2021. PMID: 34439167 Free PMC article.
38 results